Functional xenon-129 magnetic resonance imaging response to antifibrotic treatment in idiopathic pulmonary fibrosis

Andrew D Hahn; Katie J Carey; Gregory P Barton; Luis A Torres; Jeff Kammerman; Robert V Cadman; Kristine E Lee; Mark L Schiebler; Nathan Sandbo; Sean B Fain

doi:10.1183/23120541.00080-2023

Functional xenon-129 magnetic resonance imaging response to antifibrotic treatment in idiopathic pulmonary fibrosis

ERJ Open Res. 2023 Jun 26;9(3):00080-2023. doi: 10.1183/23120541.00080-2023. eCollection 2023 May.

Authors

Andrew D Hahn^{1

2}, Katie J Carey¹, Gregory P Barton^{1

3}, Luis A Torres¹, Jeff Kammerman¹, Robert V Cadman^{1

4}, Kristine E Lee⁵, Mark L Schiebler⁶, Nathan Sandbo⁴, Sean B Fain^{4

1

2}

Affiliations

¹ Department of Medical Physics, UW-Madison, Madison, WI, USA.
² Department of Radiology, University of Iowa, Iowa City, IA, USA.
³ Department of Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
⁴ Department of Medicine, UW-Madison, Madison, WI, USA.
⁵ Department of Biostatistics and Medical Informatics, UW-Madison, Madison, WI, USA.
⁶ Department of Radiology, UW-Madison, Madison, WI, USA.

Abstract

A measure of regional gas exchange on HP ¹²⁹Xe MRI was able to detect apparent improvements in IPF patients treated with antifibrotic medication after 1 year, while no such improvements were found in patients treated with conventional therapies https://bit.ly/3ZXipzD.

Abstract

Grants and funding